High serum uric acid level is a mortality risk factor in peritoneal dialysis patients: a retrospective cohort study

BackgroundThe results remain controversial with regards to the impact of serum uric acid on clinical outcomes from peritoneal dialysis population. The aim of our study was to investigate the influence of serum uric acid levels on mortality in peritoneal dialysis patients.MethodsData on 9405 peritoneal dialysis patients from the Zhejiang Renal Data system were retrospectively analyzed. All demographic and laboratory data were recorded at baseline. The study cohort was divided into quintiles according to baseline uric acid level (mg/dL): Q1 (<6.06), Q2 (6.06-6.67), Q3 (6.68-7.27) (reference), Q4 (7.28-8.03), and Q5 (>= 8.04). Hazards ratio (HR) of all-cause and cardiovascular mortality was calculated.ResultsMean serum uric acid was 7.071.25mg/dL. During a median follow-up of 29.4 (range, 3.0 to 115.4) months, 1226 (13.0%) patients died, of which 515 (5.5%) died of cardiovascular events. The Kaplan-Meier survival curves showed that patients in the middle uric acid quintile (Q3: 6.68-7.27) exhibited the highest patient and cardiovascular survival rates (log-rank test P<0.05). Multivariate Cox regression analysis showed that, using Q3 as the reference, in the fully adjusted model, a higher uric acid level (Q4: 7.28-8.03, and Q5: >= 8.04) was significantly associated with higher all-cause mortality (Model 3; Q4: HR, 1.335, 95% CI, 1.073 to 1.662, P=0.009; Q5: HR, 1.482, 95% CI, 1.187 to 1.849, P=0.001), but not with cardiovascular mortality. The adverse effect of higher uric acid level (>= 7.28mg/dL) on all-cause mortality was more prominent in groups such as male, hypoalbuminemia, normal weight, non-diabetes mellitus at baseline rather than in their counterparts respectively.Conclusions A higher uric acid level was an independent risk factor for all-cause mortality in peritoneal dialysis patients.